Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Trade this ETF at your broker
| Index | MSCI ACWI IMI Innovation Select Screened 200 |
| Investment focus | Equity, World, Social/Environmental |
| Fund size | EUR 7 m |
| Total expense ratio | 0.30% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 19.83% |
| Inception/ Listing Date | 12 July 2022 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Xtrackers |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | State Street Custodial Services (Ireland) Limited |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revision Company | Pricewaterhouse Coopers |
| Fiscal Year End | 31 December |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Tax data | Bundesanzeiger | |
| Germany | 30% tax rebate | |
| Switzerland | ESTV Reporting | |
| Austria | Tax Reporting Fund | |
| UK | UK Reporting | |
| Indextype | - |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| Roche Holding AG | 4.53% |
| Vertex Pharmaceuticals | 4.44% |
| Mastercard | 4.41% |
| Visa | 4.34% |
| Apple | 4.31% |
| NVIDIA Corp. | 4.25% |
| Microsoft | 4.20% |
| Tesla | 4.08% |
| Bristol Myers Squibb Co. | 3.48% |
| Amazon.com, Inc. | 2.84% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0.00€ | 0.00€ | View offer* | |
| 0.00€ | 0.00€ | View offer* | |
| 0.00€ | 0.00€ | View offer* | |
| 0.00€ | 0.00€ | View offer* | |
| 0.00€ | 0.00€ | View offer* |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| 0.00€ | 2934 | View offer* | |
| 0.00€ | 1522 | View offer* | |
| 1.00€ | 2653 | View offer* | |
| 0.00€ | 1888 | View offer* | |
| 0.00€ | 1627 | View offer* |
| YTD | +1.18% |
| 1 month | -2.26% |
| 3 months | +6.78% |
| 6 months | +15.21% |
| 1 year | +4.26% |
| 3 years | +60.15% |
| 5 years | - |
| Since inception (MAX) | +48.07% |
| 2024 | +29.60% |
| 2023 | +27.60% |
| 2022 | - |
| 2021 | - |
| Volatility 1 year | 19.83% |
| Volatility 3 years | 18.63% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.21 |
| Return per risk 3 years | 0.91 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -24.16% |
| Maximum drawdown 3 years | -24.16% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -24.16% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XNNV | - - | - - | - |
| Borsa Italiana | EUR | XNNV | XNNV IM XNNVEUIV | XNNV.MI XNNVEURINAV=SOLA | |
| London Stock Exchange | USD | XNNV | XNNV LN XNNVUSIV | XNNV.L XNNVUSDINAV=SOLA | |
| London Stock Exchange | GBP | XNNS | XNNS LN XNNVCHIV | XNNS.L XNNVCHFINAV=SOLA | |
| SIX Swiss Exchange | CHF | XNNV | XNNV SW XNNVGBIV | XNNV.S XNNVGBPINAV=SOLA | |
| XETRA | EUR | XNNV | XNNV GR | XNNV.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 873 | 0.40% p.a. | Accumulating | Sampling |
| Amundi MSCI Disruptive Technology UCITS ETF Acc | 159 | 0.45% p.a. | Accumulating | Full replication |
| WisdomTree Megatrends UCITS ETF USD | 30 | 0.50% p.a. | Accumulating | Full replication |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 12 | 0.35% p.a. | Accumulating | Full replication |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C 1C | 6 | 0.30% p.a. | Accumulating | Full replication |